why choose us

First received: December 13, 2022

Clinical Trial: A Study to Compare Two Different Forms of PF-07081532 in Adults Who Are Overweight or Obese

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Overweight

Study Type: INTERVENTIONAL


Official Title: A PHASE 1, OPEN-LABEL, 2-PERIOD, 2-SEQUENCE, CROSSOVER STUDY TO COMPARE THE SINGLE-DOSE PHARMACOKINETICS OF 2 DIFFERENT FORMULATIONS OF PF-07081532 ADMINISTERED ORALLY TO ADULT PARTICIPANTS WHO ARE OV

Brief Summary: The purpose of this study is to compare the amount of PF-07081532 in blood after taking two different forms of PF-07081532.This study is seeking participants who are at least 18 years of age and are overweight and/or obese.All study participants will receive a total of 2 single doses of this study medication in either form.Form A consists of a PF-07081532 20 mg immediate release tablet and a PF-07081532 60 mg immediate release tablet.Form B consists of a PF-07081532 80 mg immediate release tablet.Each single…

Read more